Anebulo Pharmaceuticals, Inc.

NASDAQ:ANEB

1.895 (USD) • At close October 29, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 3.0945.1476.6458.52111.24714.16516.35519.21414.54816.54818.00919.20819.9863.3072.48-3.025
Short Term Investments 0000000000000006.05
Cash and Short Term Investments 3.0945.1476.6458.52111.24714.16516.35519.21414.54816.54818.00919.20819.9863.3072.483.025
Net Receivables 00000000000000.02300
Inventory 0000000000000000
Other Current Assets 00.2240.1720.5270.4230.2680.5330.6021.0310.7010.9551.2931.6680.5690.0290
Total Current Assets 3.5085.3716.8169.04811.6714.43316.88819.81514.54817.24818.96420.519.9863.8992.5093.025
Non-Current Assets:
Property, Plant & Equipment, Net 0000000000000000
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 0000000000000000
Tax Assets 0000000000000000
Other Non-Current Assets 0.5650.6250.68500.42300000001.6680.3930.102-3.025
Total Non-Current Assets 0.5650.6250.68500.4230001.0310001.6680.3930.102-3.025
Total Assets 4.0735.9967.5019.04811.6714.43316.88819.81515.57917.24818.96420.521.6534.2912.6110
Liabilities & Equity:
Current Liabilities:
Account Payables 0.1560.3850.3190.5660.5350.5710.3470.5230.3810.0830.0430.4940.110.0820.0840
Short Term Debt 000000000000000.2090
Tax Payables 0000000000000000
Deferred Revenue 0000000000000000
Other Current Liabilities 0.1040.6250.6950.1510.5340.921.0260.1750.1320.0030.0070.1140.1320.2110.060
Total Current Liabilities 0.2611.011.0140.7171.0691.4911.3720.6980.5130.0860.050.6080.2420.2930.3540
Non-Current Liabilities:
Long Term Debt 0000000000000000
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 00.6250.6950.1510.5340.5711.026000.0830.04300.1113.4342.9760
Total Non-Current Liabilities 00.6250.6950.1510.5340.5711.02600.3810.0830.0430.4940.1113.4342.9760
Total Liabilities 0.2611.011.0140.7171.0691.4911.3720.6980.5130.0860.050.6080.24213.7273.330
Equity:
Preferred Stock 00000000000021.6532,975.7522.9762.976
Common Stock 0.0260.0260.0260.0260.0260.0260.0260.0260.0230.0230.0230.0230.0230.0130.0130
Retained Earnings -65.404-64.054-62.4-59.683-57.202-54.706-51.908-48.082-45.47-43.147-41.27-40.197-38.644-9.532-0.7680
Accumulated Other Comprehensive Income/Loss 00000-0-000-000-0-2,975.752-0-0.171
Other Total Stockholders Equity 69.1969.01368.86267.98967.77867.62267.39967.17360.51360.28660.16160.06738.3790.084-2.940
Total Shareholders Equity 3.8134.9856.4878.33110.60112.94215.51619.11715.06717.16318.91419.89321.412-9.436-0.7192.805
Total Equity 3.8134.9856.4878.33110.60112.94215.51619.11715.06717.16318.91419.89321.412-9.436-0.7192.805
Total Liabilities & Shareholders Equity 4.0735.9967.5019.04811.6714.43316.88819.81515.57917.24818.96420.521.6534.2912.6112.805